Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery

Paul F. White, Ozlem Sacan, Buru Tufanogullari, Matthew Eng, Nina Nuangchamnong, Babatunde Ogunnaike

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Purpose: Non-opioid analgesics are increasingly used as part of a multimodal regimen for pain management. This prospective, randomized, double-blinded, placebo-controlled study was designed to evaluate the effect of short-term postoperative administration of celecoxib on pain management and recovery outcomes following laparoscopic surgery. Methods: Eighty consenting ASA I-III outpatients undergoing laparoscopic surgery were randomly assigned to one of two treatment groups: Control (placebo) or Celecoxib (celecoxib, 400 mg·day-1). The initial dose (celecoxib 400 mg or placebo po) was administered in the recovery room, and celecoxib 200 mg (or a placebo) po bid was continued for three additional days after surgery. Postoperative pain scores and the need for opioid-containing analgesics were recorded at specific intervals in the recovery room. Follow-up evaluations were performed at 24 hr, 48 hr, 72 hr and seven days and one month after surgery to assess post-discharge pain, analgesic requirements, complications, quality of recovery, and resumption of normal activities, as well as patient satisfaction with their pain management. Results: Celecoxib reduced mean pain scores and the need for analgesics at 24 hr and 48 hr postoperatively. Patient satisfaction with their postoperative pain management was also higher in the Celecoxib group (94 ± 8 vs 80 ± 25, P < 0.05). Quality of recovery scores were significantly higher in the Celecoxib group on the first and second postoperative days (17 ± 1 vs 15 ± 2, and 18 ± 1 vs 16 ± 2, respectively). Finally, bowel function recovered an average of one day earlier and patients resumed activities of daily living two days earlier in the Celecoxib group (P < 0.05). Conclusion: Short-term administration of celecoxib, 400 mg·day-1 po, decreased postoperative pain and the need for opioid-containing analgesic medication, leading to an improved quality of recovery after outpatient laparoscopic surgery.

Original languageEnglish (US)
Pages (from-to)342-348
Number of pages7
JournalCanadian Journal of Anesthesia
Volume54
Issue number5
StatePublished - May 2007

Fingerprint

Celecoxib
Ambulatory Surgical Procedures
Laparoscopy
Pain Management
Postoperative Pain
Placebos
Analgesics
Recovery Room
Patient Satisfaction
Opioid Analgesics
Pain

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. / White, Paul F.; Sacan, Ozlem; Tufanogullari, Buru; Eng, Matthew; Nuangchamnong, Nina; Ogunnaike, Babatunde.

In: Canadian Journal of Anesthesia, Vol. 54, No. 5, 05.2007, p. 342-348.

Research output: Contribution to journalArticle

White, Paul F. ; Sacan, Ozlem ; Tufanogullari, Buru ; Eng, Matthew ; Nuangchamnong, Nina ; Ogunnaike, Babatunde. / Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. In: Canadian Journal of Anesthesia. 2007 ; Vol. 54, No. 5. pp. 342-348.
@article{473a39749db3420fb49ccfe2ce2ba827,
title = "Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery",
abstract = "Purpose: Non-opioid analgesics are increasingly used as part of a multimodal regimen for pain management. This prospective, randomized, double-blinded, placebo-controlled study was designed to evaluate the effect of short-term postoperative administration of celecoxib on pain management and recovery outcomes following laparoscopic surgery. Methods: Eighty consenting ASA I-III outpatients undergoing laparoscopic surgery were randomly assigned to one of two treatment groups: Control (placebo) or Celecoxib (celecoxib, 400 mg·day-1). The initial dose (celecoxib 400 mg or placebo po) was administered in the recovery room, and celecoxib 200 mg (or a placebo) po bid was continued for three additional days after surgery. Postoperative pain scores and the need for opioid-containing analgesics were recorded at specific intervals in the recovery room. Follow-up evaluations were performed at 24 hr, 48 hr, 72 hr and seven days and one month after surgery to assess post-discharge pain, analgesic requirements, complications, quality of recovery, and resumption of normal activities, as well as patient satisfaction with their pain management. Results: Celecoxib reduced mean pain scores and the need for analgesics at 24 hr and 48 hr postoperatively. Patient satisfaction with their postoperative pain management was also higher in the Celecoxib group (94 ± 8 vs 80 ± 25, P < 0.05). Quality of recovery scores were significantly higher in the Celecoxib group on the first and second postoperative days (17 ± 1 vs 15 ± 2, and 18 ± 1 vs 16 ± 2, respectively). Finally, bowel function recovered an average of one day earlier and patients resumed activities of daily living two days earlier in the Celecoxib group (P < 0.05). Conclusion: Short-term administration of celecoxib, 400 mg·day-1 po, decreased postoperative pain and the need for opioid-containing analgesic medication, leading to an improved quality of recovery after outpatient laparoscopic surgery.",
author = "White, {Paul F.} and Ozlem Sacan and Buru Tufanogullari and Matthew Eng and Nina Nuangchamnong and Babatunde Ogunnaike",
year = "2007",
month = "5",
language = "English (US)",
volume = "54",
pages = "342--348",
journal = "Canadian Journal of Anesthesia",
issn = "0832-610X",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery

AU - White, Paul F.

AU - Sacan, Ozlem

AU - Tufanogullari, Buru

AU - Eng, Matthew

AU - Nuangchamnong, Nina

AU - Ogunnaike, Babatunde

PY - 2007/5

Y1 - 2007/5

N2 - Purpose: Non-opioid analgesics are increasingly used as part of a multimodal regimen for pain management. This prospective, randomized, double-blinded, placebo-controlled study was designed to evaluate the effect of short-term postoperative administration of celecoxib on pain management and recovery outcomes following laparoscopic surgery. Methods: Eighty consenting ASA I-III outpatients undergoing laparoscopic surgery were randomly assigned to one of two treatment groups: Control (placebo) or Celecoxib (celecoxib, 400 mg·day-1). The initial dose (celecoxib 400 mg or placebo po) was administered in the recovery room, and celecoxib 200 mg (or a placebo) po bid was continued for three additional days after surgery. Postoperative pain scores and the need for opioid-containing analgesics were recorded at specific intervals in the recovery room. Follow-up evaluations were performed at 24 hr, 48 hr, 72 hr and seven days and one month after surgery to assess post-discharge pain, analgesic requirements, complications, quality of recovery, and resumption of normal activities, as well as patient satisfaction with their pain management. Results: Celecoxib reduced mean pain scores and the need for analgesics at 24 hr and 48 hr postoperatively. Patient satisfaction with their postoperative pain management was also higher in the Celecoxib group (94 ± 8 vs 80 ± 25, P < 0.05). Quality of recovery scores were significantly higher in the Celecoxib group on the first and second postoperative days (17 ± 1 vs 15 ± 2, and 18 ± 1 vs 16 ± 2, respectively). Finally, bowel function recovered an average of one day earlier and patients resumed activities of daily living two days earlier in the Celecoxib group (P < 0.05). Conclusion: Short-term administration of celecoxib, 400 mg·day-1 po, decreased postoperative pain and the need for opioid-containing analgesic medication, leading to an improved quality of recovery after outpatient laparoscopic surgery.

AB - Purpose: Non-opioid analgesics are increasingly used as part of a multimodal regimen for pain management. This prospective, randomized, double-blinded, placebo-controlled study was designed to evaluate the effect of short-term postoperative administration of celecoxib on pain management and recovery outcomes following laparoscopic surgery. Methods: Eighty consenting ASA I-III outpatients undergoing laparoscopic surgery were randomly assigned to one of two treatment groups: Control (placebo) or Celecoxib (celecoxib, 400 mg·day-1). The initial dose (celecoxib 400 mg or placebo po) was administered in the recovery room, and celecoxib 200 mg (or a placebo) po bid was continued for three additional days after surgery. Postoperative pain scores and the need for opioid-containing analgesics were recorded at specific intervals in the recovery room. Follow-up evaluations were performed at 24 hr, 48 hr, 72 hr and seven days and one month after surgery to assess post-discharge pain, analgesic requirements, complications, quality of recovery, and resumption of normal activities, as well as patient satisfaction with their pain management. Results: Celecoxib reduced mean pain scores and the need for analgesics at 24 hr and 48 hr postoperatively. Patient satisfaction with their postoperative pain management was also higher in the Celecoxib group (94 ± 8 vs 80 ± 25, P < 0.05). Quality of recovery scores were significantly higher in the Celecoxib group on the first and second postoperative days (17 ± 1 vs 15 ± 2, and 18 ± 1 vs 16 ± 2, respectively). Finally, bowel function recovered an average of one day earlier and patients resumed activities of daily living two days earlier in the Celecoxib group (P < 0.05). Conclusion: Short-term administration of celecoxib, 400 mg·day-1 po, decreased postoperative pain and the need for opioid-containing analgesic medication, leading to an improved quality of recovery after outpatient laparoscopic surgery.

UR - http://www.scopus.com/inward/record.url?scp=34249022150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249022150&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 342

EP - 348

JO - Canadian Journal of Anesthesia

JF - Canadian Journal of Anesthesia

SN - 0832-610X

IS - 5

ER -